Oncolytics Biotech Inc. (TSX:ONC)
Canada
· Delayed Price · Currency is CAD 0.7200
+0.0200 (2.86%)
May 8, 2025, 3:59 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 28 employees as of December 31, 2024. The number of employees decreased by 1 or -3.45% compared to the previous year.
Employees
28
Change
-1
Growth
-3.45%
Revenue / Employee
n/a
Profits / Employee
-1.13M CAD
Market Cap
62.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Green Thumb Industries | 4,800 |
| dentalcorp Holdings | 10,200 |
| Sienna Senior Living | 12,263 |
| Trulieve Cannabis | 6,000 |
| Extendicare | 23,000 |
| Cronos Group | 459 |
| WELL Health Technologies | 1,507 |
| Curaleaf Holdings | 5,519 |
Oncolytics Biotech News
- 3 days ago - Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights - PRNewsWire
- 15 days ago - Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action - PRNewsWire
- 4 weeks ago - Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital - PRNewsWire
- 4 weeks ago - Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers - PRNewsWire
- 2 months ago - Oncolytics Biotech: Continuing To Justify The Negativity - Seeking Alpha
- 2 months ago - Oncolytics Biotech Inc. (ONCY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Oncolytics Biotech GAAP EPS of -$0.41 misses by $0.10 - Seeking Alpha
- 2 months ago - Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024 - Benzinga